Ventripoint Diagnostics Ltd. (VPT.V)
TSXV · CAD · Healthcare · Medical Devices
CA$0.08 (-15.79%) as of
Key statistics
- Market cap
- 15.43M
- EPS (TTM)
- -0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.0750 – 0.1900
- Beta
- 0.20
- Revenue (TTM)
- 147.77k
- Profit margin
- 0.00%
- Volume
- 436.02k
About Ventripoint Diagnostics Ltd.
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Toronto, ON, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.